FIELD: biotechnology.
SUBSTANCE: invention relates to a method for identifying one or more neoantigens from a tumor cell, and can be used in medicine.
EFFECT: proposed method for identification of neoantigens, including simulation of presentation of neoantigens, can be used for preparing anticancer vaccines.
78 cl, 14 dwg, 1 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEOANTIGEN VECTORS BASED ON ALPHAVIRUS | 2018 |
|
RU2803566C2 |
| SELECTING CANCER MUTATIONS TO CREATE PERSONALIZED CANCER VACCINE | 2019 |
|
RU2809620C2 |
| PREDICTION OF IMMUNOGENICITY OF T-CELL EPITOPES | 2014 |
|
RU2724370C2 |
| METHOD FOR TREATING CANCER | 2016 |
|
RU2770447C2 |
| METHODS OF PREDICTING THE APPLICABILITY OF DISEASE-SPECIFIC AMINO ACID MODIFICATIONS FOR IMMUNOTHERAPY | 2018 |
|
RU2799341C2 |
| METHOD | 2016 |
|
RU2739036C2 |
| OBTAINING ANTIGEN-SPECIFIC T-CELLS | 2017 |
|
RU2745319C2 |
| METHODS FOR PREDICTION OF APPLICABILITY OF PROTEINS OR PROTEIN FRAGMENTS FOR IMMUNOTHERAPY | 2017 |
|
RU2782336C2 |
| INDIVIDUALISED VACCINES FOR CANCER | 2012 |
|
RU2670745C9 |
| INDIVIDUALIZED ANTI-TUMOR VACCINES | 2012 |
|
RU2779946C2 |
